Status:
COMPLETED
Trial of Neurostimulation and Blood Flow Restriction for PFPS in Active Duty
Lead Sponsor:
University of Tennessee
Collaborating Sponsors:
Blanchfield Army Community Hospital
Conditions:
Patellofemoral Pain Syndrome
Eligibility:
All Genders
18-44 years
Phase:
NA
Brief Summary
The overall objective of this project is to compare two self-managed treatment regimens for PFPS: (1) NMES-Exercise supplemented with high BFR LOP of 80% and (2) NMES Exercise augmented with a low per...
Detailed Description
The long-term goal is to identify effective self-managed therapies for military members that will return them to duty as quickly as possible. The overall objective of this project is to compare two se...
Eligibility Criteria
Inclusion
- \- Active duty military personnel who are:
- diagnosed with knee pain, categorized as anterior or retropatellar in one or both knees;
- self-reported difficulty performing at least two or more of the following activities associated with knee pain: prolonged sitting, stair climbing, running, jumping, and repetitive movements such as kneeling or squatting or stooping;
- military service member at the time of diagnosis and length of study;
- age ≥18 and \<45 years; and
- able to provide freely given informed consent.
Exclusion
- fracture or injury to external knee structures such that knee extension or flexion is impaired;
- a significant co-morbid medical condition (such as severe hypertension, neurological disorder, sickle cell anemia, or pacemaker/defibrillator) in which BFR, NMES strength training, or unsupervised exercise is contraindicated and would pose a safety threat or impair ability to participate;
- previous knee surgeries (i.e., tibiofemoral, patellofemoral) excluding knee arthroscopy \> 3 years;
- knee instability or recurrent patella dislocation or subluxation;
- inability or unwillingness to participate in an exercise or strengthening program;
- reduced sensory perception in the lower extremities;
- pregnancy;
- Any vascular disorder (varicose veins, Hx of DVT); or
- unwillingness to accept random assignment.
Key Trial Info
Start Date :
August 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT04086615
Start Date
August 4 2020
End Date
March 31 2022
Last Update
June 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Blanchfield Army Community Hospital (BACH)
Fort Campbell North, Kentucky, United States, 42223